Light-activated antitumor drug could inspire new cancer treatments that have minimal side effects
RIKEN chemists have demonstrated a gold-nanocluster system that carries two components of a drug in a controlled ratio for maximum cancer-cell killing effect. The active drug remains safely masked until red light triggers its release, minimizing collateral damage to healthy cells near the tumor. The study is published in Chemical Science. ⌘ Read more